Federica Perrone

University of Parma — Italy

Medicine · Health Sciences

63h-index13.0kcitations559works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(140), Lung Cancer Treatments and Mutations(112), Cancer Genomics and Diagnostics(99), Cancer Treatment and Pharmacology(55), Head and Neck Cancer Studies(54)

Publications555 total

Planning and allocating resources for pharmaceuticals to health care organisations: a proposal from the Regional Pharmaceutical Policies Forum
Global & Regional Health Technology Assessment·2025Open Access
The impact of body mass index on survival and surgical outcomes in ovarian cancer: insights from the MITO trials
International Journal of Gynecological Cancer·2025
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)
ESMO Open·2025· 1 citedOpen Access
P1.11.24 Real-World Evidence of Primary Resistance to First-Line Chemo-Immunotherapy in Advanced Lung Adenocarcinoma
Journal of Thoracic Oncology·2025
Leveraging Real-World Data From a Clinicogenomic Database Addresses the Treatment Gap in Patients With High-Grade Serous Ovarian Cancer
JCO Precision Oncology·2025Open Access
Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer
Frontiers in Oncology·2025· 4 citedOpen Access
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients
Tumori Journal·2025Open Access
The BioSUD Biobank as a genomic resource for substance use disorders in Italy
Scientific Reports·2025Open Access
Sexual health in cancer care: a narrative review and position statement from the Italian Association of Medical Oncology (AIOM)
ESMO Open·2025· 1 citedOpen Access
Programmed death‐ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV‐2 translational study
Clinical and Translational Medicine·2025· 2 citedOpen Access
Real-World Outcomes of Molecular Tumor Board Treatment Recommendations
JCO Precision Oncology·2025· 1 citedOpen Access
HR-SC—an academic-developed machine learning framework to classify HRD-positive ovarian cancer patients and predict sensitivity to olaparib
ESMO Open·2025· 1 citedOpen Access
Clinical evaluation of the role of miRNA 371 in small testicular masses. Results of the “S1STeM 371” Trial
European Journal of Cancer·2025· 3 cited
Effect of immuno-oncology on clinical and economic outcomes for a selection of cancers in Italy
Expert Review of Pharmacoeconomics & Outcomes Research·2025
Vaccination of people with solid tumors and diabetes: existing evidence and recommendations. A position statement from a multidisciplinary panel of scientific societies
Journal of Endocrinological Investigation·2025· 1 citedOpen Access
Abstract 676: First in man microdose trial of [68Ga]Ga-R54, CXCR4 targeted PET tracer: Comparison with [18F]-FDG and proof of concept in lung cancer models
Cancer Research·2025
87P: Genomic alterations and resistance mechanisms in ALK-rearranged non-small cell lung cancer: Insights from NGS profiling and clinical outcomes
Journal of Thoracic Oncology·2025Open Access
767 FGFR3 p.Arg248Cys Mutation is Prevalent in Lynch Syndrome Associated Urothelial Carcinoma – A Single Institution Dataset
Laboratory Investigation·2025
Supplementary Figure 7 from Active Surveillance in Patients with Extra-abdominal Desmoid-Type Fibromatosis: A Pooled Analysis of Three Prospective Observational Studies
2025Open Access
Supplementary Table 1 from Active Surveillance in Patients with Extra-abdominal Desmoid-Type Fibromatosis: A Pooled Analysis of Three Prospective Observational Studies
2025Open Access
page 1 of 28Next →

Frequent Co-authors

Silvana Pilotti(15), Lisa Licitra(13), Marco A. Pierotti(13), Paolo Bossi(12), Elena Tamborini(10), Laura D. Locati(9), Filippo de Braud(9), Pasquale Quattrone(8), Maria Di Bartolomeo(8), Massimo Di Maïo(8), Cristiana Bergamini(7), Filippo Pietrantonio(7), Annunziata Gloghini(7), Adele Busico(7), Barbara Cortelazzi(7), Federica Morano(6), Chiara Cremolini(6), Luigi Mariani(5), Maria Oggionni(5), Marta Orsenigo(5)